Another study by Su et al. [29] suggested that ECSOD polymorphism was significantly associated with HCC risk in non-HBV carriers, but no significant association was observed between MnSOD, CAT and GPx polymorphisms and HCC susceptibility in Chinese (434 cases and 480 control). This evidence concerns the gene CAT and hepatocellular carcinoma.